Literature DB >> 24412832

Valve surgery in active endocarditis patients complicated by intracranial haemorrhage: the influence of the timing of surgery on neurological outcomes.

Daisuke Yoshioka1, Koichi Toda1, Taichi Sakaguchi1, Shuhei Okazaki2, Takashi Yamauchi1, Shigeru Miyagawa1, Hiroyuki Nishi1, Yasushi Yoshikawa1, Satsuki Fukushima1, Tetsuya Saito1, Yoshiki Sawa3.   

Abstract

OBJECTIVES: The risk of neurological deterioration during valve surgery using cardiopulmonary bypass under systemic heparinization in infective endocarditis (IE) patients with intracranial haemorrhage (ICH) is unknown. The objective of this retrospective study was to investigate the stratified risk related to the timing of valve surgery on neurological outcomes in patients with active IE and preoperative ICH.
METHODS: From 2004 to 2012, 246 patients underwent valve surgery for IE in hospitals enrolled in the Osaka Cardiovascular Research Group. Of these, a group of 30 patients had preoperative ICH, and they included 18 patients with cerebral haemorrhage, 8 with subarachnoid haemorrhage and 4 with haemorrhagic infarction. The preoperative characteristics, neurological statuses and postoperative results of these patients were retrospectively explored to analyse the effects of the timing of surgery on neurological outcomes.
RESULTS: Twenty-one patients had symptomatic ICH, and the median modified Rankin score was 1.5 (95% confidence interval [CI] 1.2-2.8). Eight patients were diagnosed with mycotic aneurysms, and 7 of these patients underwent aneurysm resection or clipping before valve surgery. All 30 patients underwent valve surgery, and the median interval between ICH onset and surgery was 22.5 (95% CI 15.5-39.4) days. Four patients died of multiple organ dysfunction or heart failure. The interval between ICH onset and valve surgery was within 7 days for 5 cases, between 8 and 14 days for 6, between 15 and 28 days for 9 and >29 days for 10. Postoperative neuroimaging showed that neither neurological deterioration nor exacerbation of haemorrhagic lesions had occurred among the 30 patients, regardless of the timing of surgery. However, 2 cases who underwent valve surgery 8 and 81 days after the onset of ICH developed new ectopic asymptomatic haemorrhages postoperatively.
CONCLUSIONS: The risk of postoperative neurological deterioration resulting from the exacerbation of haemorrhagic lesions seemed relatively low, even in IE patients who underwent valve surgery within 2 weeks of ICH onset. However, further evaluation of the sizes and aetiologies of haemorrhagic lesions is vital to establish a safe interval between the ICH onset and surgery.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Endocarditis; Heart valve; Intracranial haemorrhage; Stroke

Mesh:

Year:  2014        PMID: 24412832     DOI: 10.1093/ejcts/ezt547

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

1.  Effect of cerebral embolus size on the timing of cardiac surgery for infective endocarditis in patients with neurological complications.

Authors:  Yong Kyun Kim; Choong Gon Choi; Jiwon Jung; Shi Nae Yu; Ju Young Lee; Yong Pil Chong; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-06       Impact factor: 3.267

2.  Successful anticoagulation therapy for a giant left atrial thrombus following mitral valve repair.

Authors:  Eshani N Mathew; Philip Y K Pang; Makoto Mori; Yeow Leng Chua; Yoong Kong Sin
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 3.  Neurologic Complications of Infective Endocarditis: Recent Findings.

Authors:  Marie Cantier; Mikael Mazighi; Isabelle Klein; J P Desilles; Michel Wolff; J F Timsit; Romain Sonneville
Journal:  Curr Infect Dis Rep       Date:  2017-09-19       Impact factor: 3.725

4.  Early Operation for Endocarditis Complicated by Preoperative Cerebral Emboli Is Not Associated With Worsened Outcomes.

Authors:  Robert A Sorabella; Sang Myung Han; Mark Grbic; Yeu Sanz Wu; Hiroo Takyama; Paul Kurlansky; Michal A Borger; Michael Argenziano; Rachel Gordon; Isaac George
Journal:  Ann Thorac Surg       Date:  2015-06-24       Impact factor: 4.330

Review 5.  Surgical Timing in Patients With Infective Endocarditis and With Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.

Authors:  Rita Musleh; Peter Schlattmann; Túlio Caldonazo; Hristo Kirov; Otto W Witte; Torsten Doenst; Albrecht Günther; Mahmoud Diab
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

6.  Neurological Outcomes of Patients With Mycotic Aneurysms in Infective Endocarditis.

Authors:  Hang Shi; Neal S Parikh; Charles Esenwa; Richard Zampolin; Harsh Shah; Farid Khasiyev; Ives Valenzuela; Sean Lavine; Jose Gutierrez; Joshua Willey
Journal:  Neurohospitalist       Date:  2020-06-15

7.  Inactive large cerebral hemorrhage is not exacerbated by the adjustment of anticoagulation post open-heart surgery.

Authors:  Ayaka Satoh; Shin Yajima; Naosumi Sekiya; Sachiko Yamazaki; Hisashi Uemura; Daisuke Ueda; Hiroe Tanaka; Mitsuhiro Yamamura; Taichi Sakaguchi
Journal:  J Cardiol Cases       Date:  2021-05-13

8.  Emergency valve surgery for infective endocarditis complicated by acute intracranial hemorrhage: A case report.

Authors:  Takasumi Goto; Toshihiro Ohata; Takayuki Shijo; Daisuke Yoshioka; Mitsunori Kaneko
Journal:  Int J Surg Case Rep       Date:  2017-02-11

9.  Aortic and tricuspid endocarditis in hemodialysis patient with systemic and pulmonary embolism.

Authors:  Silvia Aguiar Rosa; Nuno Germano; Ana Santos; Luis Bento
Journal:  Rev Bras Ter Intensiva       Date:  2015 Apr-Jun

10.  Lethal infective endocarditis due to Streptococcus agalactiae in a man with a history of alcohol abuse: A case report.

Authors:  Myriam D'Angelo; Ilaria Boretti; Salvina Quattrocchi; Giovanni Alongi; Carmela Rifici; Francesco Corallo; Angela Magazù; Demetrio Milardi; Gaetano Cannavà; Placido Bramanti; Antonio Duca
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.